Based on the GEPIA web-based tool and the results from our recruited cohort, we found that TP53, RFC2, TAF10, UMPS and SEC61A1 were overexpressed in EC patients, while DDB2 was downregulated in cancer tissues (Fig. S3, Fig. 3). Here, TP53 is linked to cancer.